Adipose-Derived Stem Cells Promote Angiogenesis and Tissue Formation for In Vivo Tissue Engineering
Publication: Tissue Engineering Part A
Volume 19, Issue Number 11-12
Abstract
Adult mesenchymal stem cells secrete a variety of angiogenic cytokines and growth factors, so we proposed that these paracrine mechanisms may be used to promote vascularization and growth for tissue engineering in vivo. We tested whether or not human adipose-derived stem cells (ASCs) promote tissue formation in rats. ASCs were evaluated in vitro for mRNA expression of angiogenic factors, including the vascular endothelial growth factor, basic fibroblast growth factor, interleukin-8 (IL-8), and stromal cell-derived factor-1 (SDF-1) and proliferative activity on human microvascular endothelial cells. For in vivo analysis, CM-DiI-labeled ASCs were implanted with a rat cardiac extracellular matrix (ECM) extract-derived hydrogel into a chamber with a femoral arteriovenous loop in the groin of male nude rats for 7 days. Vascularization in newly generated tissue was estimated by histomorphometry after endothelial nitric oxide synthase (eNOS) immunostaining. ASCs expressed growth factor mRNA and produced an angiogenic activity in vitro. After implantation, ASCs survived, but remained suspended in the ECM and relatively few were incorporated into the newly formed tissue. The volume of newly generated tissue was significantly higher in chambers containing ASCs and it was enriched with vasculature when compared with the ECM alone. We conclude that human ASCs promote tissue growth and angiogenesis in the rat vascularized chamber, thereby showing promise for tissue-engineering applications for regenerative therapy.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Murry C.E.Reinecke H.Pabon L.M. Regeneration gaps: observations on stem cells and cardiac repairJ Am Coll Cardiol4717772006. 1. Murry, C.E., Reinecke, H., and Pabon, L.M. Regeneration gaps: observations on stem cells and cardiac repair. J Am Coll Cardiol 47, 1777, 2006.
2.
Fuchs S.Baffour R.Zhou Y.F.Shou M.Pierre A.Tio F.O. et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemiaJ Am Coll Cardiol3717262001. 2. Fuchs, S., Baffour, R., Zhou, Y.F., Shou, M., Pierre, A., Tio, F.O., et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 37, 1726, 2001.
3.
Kamihata H.Matsubara H.Nishiue T.Fujiyama S.Tsutsumi Y.Ozono R. et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokinesCirculation10410462001. 3. Kamihata, H., Matsubara, H., Nishiue, T., Fujiyama, S., Tsutsumi, Y., Ozono, R., et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104, 1046, 2001.
4.
Kinnaird T.Stabile E.Burnett M.S.Shou M.Lee C.W.Barr S. et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanismsCirculation10915432004. 4. Kinnaird, T., Stabile, E., Burnett, M.S., Shou, M., Lee, C.W., Barr, S., et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109, 1543, 2004.
5.
Rehman J.Traktuev D.Li J.Merfeld-Clauss S.Temm-Grove C.J.Bovenkerk J.E. et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cellsCirculation10912922004. 5. Rehman, J., Traktuev, D., Li, J., Merfeld-Clauss, S., Temm-Grove, C.J., Bovenkerk, J.E., et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109, 1292, 2004.
6.
Hsiao S.T.Asgari A.Lokmic Z.Sinclair R.Dusting G.J.Lim S.Y.Dilley R.J. Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissueStem Cells Dev2121892012. 6. Hsiao, S.T., Asgari, A., Lokmic, Z., Sinclair, R., Dusting, G.J., Lim, S.Y., and Dilley, R.J. Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue. Stem Cells Dev 21, 2189, 2012.
7.
See F.Seki T.Psaltis P.J.Sondermeijer H.P.Gronthos S.Zannettino A.C.Govaert K.M.Schuster M.D.Kurlansky P.A.Kelly D.J.Krum H.Itescu S. Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemiaJ Cell Mol Med1521172011. 7. See, F., Seki, T., Psaltis, P.J., Sondermeijer, H.P., Gronthos, S., Zannettino, A.C., Govaert, K.M., Schuster, M.D., Kurlansky, P.A., Kelly, D.J., Krum, H., and Itescu, S. Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia. J Cell Mol Med 15, 2117, 2011.
8.
Amos P.J.Shang H.Bailey A.M.Taylor A.Katz A.J.Peirce S.M. IFATS collection: the role of human adipose-derived stromal cells in inflammatory microvascular remodeling and evidence of a perivascular phenotypeStem Cells2626822008. 8. Amos, P.J., Shang, H., Bailey, A.M., Taylor, A., Katz, A.J., and Peirce, S.M. IFATS collection: the role of human adipose-derived stromal cells in inflammatory microvascular remodeling and evidence of a perivascular phenotype. Stem Cells 26, 2682, 2008.
9.
Choi Y.S.Matsuda K.Dusting G.J.Morrison W.A.Dilley R.J. Engineering cardiac tissue in vivo from human adipose-derived stem cellsBiomaterials3122362010. 9. Choi, Y.S., Matsuda, K., Dusting, G.J., Morrison, W.A., and Dilley, R.J. Engineering cardiac tissue in vivo from human adipose-derived stem cells. Biomaterials 31, 2236, 2010.
10.
Amoh Y.Li L.Yang M.Moossa A.R.Katsuoka K.Penman S.Hoffman R.M. Nascent blood vessels in the skin arise from nestin-expressing hair-follicle cellsProc Natl Acad Sci U S A101132912004. 10. Amoh, Y., Li, L., Yang, M., Moossa, A.R., Katsuoka, K., Penman, S., and Hoffman, R.M. Nascent blood vessels in the skin arise from nestin-expressing hair-follicle cells. Proc Natl Acad Sci U S A 101, 13291, 2004.
11.
Gnecchi M.Zhang Z.Ni A.Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapyCirc Res10312042008. 11. Gnecchi, M., Zhang, Z., Ni, A., and Dzau, V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103, 1204, 2008.
12.
Levenberg S.Rouwkema J.Macdonald M.Garfein E.S.Kohane D.S.Darland D.C.Marini R.van Blitterswijk C.A.Mulligan R.C.D'Amore P.A.Langer R. Engineering vascularized skeletal muscle tissueNat Biotechnol238792005. 12. Levenberg, S., Rouwkema, J., Macdonald, M., Garfein, E.S., Kohane, D.S., Darland, D.C., Marini, R., van Blitterswijk, C.A., Mulligan, R.C., D'Amore, P.A., and Langer, R. Engineering vascularized skeletal muscle tissue. Nat Biotechnol 23, 879, 2005.
13.
Mian R.Morrison W.A.Hurley J.V.Penington A.J.Romeo R.Tanaka Y. et al. Formation of new tissue from an arteriovenous loop in the absence of added extracellular matrixTissue Eng65952000. 13. Mian, R., Morrison, W.A., Hurley, J.V., Penington, A.J., Romeo, R., Tanaka, Y., et al. Formation of new tissue from an arteriovenous loop in the absence of added extracellular matrix. Tissue Eng 6, 595, 2000.
14.
Lokmic Z.Stillaert F.Morrison W.A.Thompson E.W.Mitchell G.M. An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered constructFASEB J215112007. 14. Lokmic, Z., Stillaert, F., Morrison, W.A., Thompson, E.W., and Mitchell, G.M. An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered construct. FASEB J 21, 511, 2007.
15.
Morritt A.N.Bortolotto S.K.Dilley R.J.Han X.Kompa A.R.McCombe D. et al. Cardiac tissue engineering in an in vivo vascularized chamberCirculation1153532007. 15. Morritt, A.N., Bortolotto, S.K., Dilley, R.J., Han, X., Kompa, A.R., McCombe, D., et al. Cardiac tissue engineering in an in vivo vascularized chamber. Circulation 115, 353, 2007.
16.
Tee R.Morrison W.A.Dusting G.J.Liu G.Choi Y.S.Hsiao S.T.Dilley R.J. Transplantation of engineered cardiac muscle flaps in syngeneic ratsTissue Eng A(In Press). 16. Tee, R., Morrison, W.A., Dusting, G.J., Liu, G., Choi, Y.S., Hsiao, S.T., and Dilley, R.J. Transplantation of engineered cardiac muscle flaps in syngeneic rats. Tissue Eng A (In Press).
17.
Choi Y.S.Dusting G.J.Stubbs S.Arunothayaraj S.Han X.L.Collas P.Morrison W.A.Dilley R.J. Differentiation of human adipose-derived stem cells into beating cardiomyocytesJ Cell Mol Med148782010. 17. Choi, Y.S., Dusting, G.J., Stubbs, S., Arunothayaraj, S., Han, X.L., Collas, P., Morrison, W.A., and Dilley, R.J. Differentiation of human adipose-derived stem cells into beating cardiomyocytes. J Cell Mol Med 14, 878, 2010.
18.
Lokmic Z.Mitchell G.M. Engineering the microcirculationTissue Eng Part B Rev14872008. 18. Lokmic, Z., and Mitchell, G.M. Engineering the microcirculation. Tissue Eng Part B Rev 14, 87, 2008.
19.
Kilroy G.E.Foster S.J.Wu X.Ruiz J.Sherwood S.Heifetz A.Ludlow J.W.Stricker D.M.Potiny S.Green P.Halvorsen Y.D.Cheatham B.Storms R.W.Gimble J.M. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factorsJ Cell Physiol2127022007. 19. Kilroy, G.E., Foster, S.J., Wu, X., Ruiz, J., Sherwood, S., Heifetz, A., Ludlow, J.W., Stricker, D.M., Potiny, S., Green, P., Halvorsen, Y.D., Cheatham, B., Storms, R.W., and Gimble, J.M. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 212, 702, 2007.
20.
Altman A.M.Yan Y.Matthias N.Bai X.Rios C.Mathur A.B. et al. IFATS collection: human adipose-derived stem cells seeded on a silk fibroin-chitosan scaffold enhance wound repair in a murine soft tissue injury modelStem Cells272502009. 20. Altman, A.M., Yan, Y., Matthias, N., Bai, X., Rios, C., Mathur, A.B., et al. IFATS collection: human adipose-derived stem cells seeded on a silk fibroin-chitosan scaffold enhance wound repair in a murine soft tissue injury model. Stem Cells 27, 250, 2009.
21.
Chen J.Li Y.Katakowski M.Chen X.Wang L.Lu D. et al. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female ratJ Neurosci Res737782003. 21. Chen, J., Li, Y., Katakowski, M., Chen, X., Wang, L., Lu, D., et al. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 73, 778, 2003.
22.
Li Y.McIntosh K.Chen J.Zhang C.Gao Q.Borneman J. et al. Allogeneic bone marrow stromal cells promote glial-axonal remodeling without immunologic sensitization after stroke in ratsExp Neurol1983132006. 22. Li, Y., McIntosh, K., Chen, J., Zhang, C., Gao, Q., Borneman, J., et al. Allogeneic bone marrow stromal cells promote glial-axonal remodeling without immunologic sensitization after stroke in rats. Exp Neurol 198, 313, 2006.
23.
Tang Y.L.Zhao Q.Qin X.Shen L.Cheng L.Ge J. et al. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarctionAnn Thorac Surg802292005. 23. Tang, Y.L., Zhao, Q., Qin, X., Shen, L., Cheng, L., Ge, J., et al. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg 80, 229, 2005.
24.
Min J.Y.Sullivan M.F.Yang Y.Zhang J.P.Converso K.L.Morgan J.P. et al. Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigsAnn Thorac Surg7415682002. 24. Min, J.Y., Sullivan, M.F., Yang, Y., Zhang, J.P., Converso, K.L., Morgan, J.P., et al. Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs. Ann Thorac Surg 74, 1568, 2002.
25.
Kawada H.Fujita J.Kinjo K.Matsuzaki Y.Tsuma M.Miyatake H. et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarctionBlood10435812004. 25. Kawada, H., Fujita, J., Kinjo, K., Matsuzaki, Y., Tsuma, M., Miyatake, H., et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104, 3581, 2004.
26.
Caplan A.I.Dennis J.E. Mesenchymal stem cells as trophic mediatorsJ Cell Biochem9810762006. 26. Caplan, A.I., and Dennis, J.E. Mesenchymal stem cells as trophic mediators. J Cell Biochem 98, 1076, 2006.
27.
Li Y.Chen J.Zhang C.L.Wang L.Lu D.Katakowski M. et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cellsGlia494072005. 27. Li, Y., Chen, J., Zhang, C.L., Wang, L., Lu, D., Katakowski, M., et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 49, 407, 2005.
28.
Boomsma R.A.Swaminathan P.D.Geenen D.L. Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct sizeInt J Cardiol122172007. 28. Boomsma, R.A., Swaminathan, P.D., and Geenen, D.L. Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size. Int J Cardiol 122, 17, 2007.
29.
Lu Y.Shansky J.Del Tatto M.Ferland P.Wang X.Vandenburgh H. Recombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial muscles promotes localized angiogenesisCirculation1045942001. 29. Lu, Y., Shansky, J., Del Tatto, M., Ferland, P., Wang, X., and Vandenburgh, H. Recombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial muscles promotes localized angiogenesis. Circulation 104, 594, 2001.
30.
Sprugel K.H.McPherson J.M.Clowes A.W.Ross R. Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambersAm J Pathol1296011987. 30. Sprugel, K.H., McPherson, J.M., Clowes, A.W., and Ross, R. Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers. Am J Pathol 129, 601, 1987.
31.
Lee K.Y.Peters M.C.Mooney D.J. Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID miceJ Control Release87492003. 31. Lee, K.Y., Peters, M.C., and Mooney, D.J. Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice. J Control Release 87, 49, 2003.
32.
Peters M.C.Isenberg B.C.Rowley J.A.Mooney D.J. Release from alginate enhances the biological activity of vascular endothelial growth factorJ Biomater Sci Polym Ed912671998. 32. Peters, M.C., Isenberg, B.C., Rowley, J.A., and Mooney, D.J. Release from alginate enhances the biological activity of vascular endothelial growth factor. J Biomater Sci Polym Ed 9, 1267, 1998.
33.
Ikada Y.Tabata Y. Protein release from gelatin matricesAdv Drug Deliv Rev312871998. 33. Ikada, Y., and Tabata, Y. Protein release from gelatin matrices. Adv Drug Deliv Rev 31, 287, 1998.
34.
Tabata Y.Nagano A.Ikada Y. Biodegradation of hydrogel carrier incorporating fibroblast growth factorTissue Eng51271999. 34. Tabata, Y., Nagano, A., and Ikada, Y. Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng 5, 127, 1999.
35.
Murphy W.L.Peters M.C.Kohn D.H.Mooney D.J. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineeringBiomaterials2125212000. 35. Murphy, W.L., Peters, M.C., Kohn, D.H., and Mooney, D.J. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 21, 2521, 2000.
36.
Eiselt P.Kim B.S.Chacko B.Isenberg B.Peters M.C.Greene K.G. et al. Development of technologies aiding large-tissue engineeringBiotechnol Prog141341998. 36. Eiselt, P., Kim, B.S., Chacko, B., Isenberg, B., Peters, M.C., Greene, K.G., et al. Development of technologies aiding large-tissue engineering. Biotechnol Prog 14, 134, 1998.
37.
Elcin Y.M.Dixit V.Gitnick G. Controlled release of endothelial cell growth factor from chitosan-albumin microspheres for localized angiogenesis: in vitro and in vivo studiesArtif Cells Blood Substit Immobil Biotechnol242571996. 37. Elcin, Y.M., Dixit, V., and Gitnick, G. Controlled release of endothelial cell growth factor from chitosan-albumin microspheres for localized angiogenesis: in vitro and in vivo studies. Artif Cells Blood Substit Immobil Biotechnol 24, 257, 1996.
38.
Wilcke I.Lohmeyer J.A.Liu S.Condurache A.Krüger S.Mailänder P. et al. VEGF(165) and bFGF protein-based therapy in a slow release system to improve angiogenesis in a bioartificial dermal substitute in vitro and in vivoLangenbecks Arch Surg3923052007. 38. Wilcke, I., Lohmeyer, J.A., Liu, S., Condurache, A., Krüger, S., Mailänder, P., et al. VEGF(165) and bFGF protein-based therapy in a slow release system to improve angiogenesis in a bioartificial dermal substitute in vitro and in vivo. Langenbecks Arch Surg 392, 305, 2007.
39.
Arkudas A.Pryymachuk G.Hoereth T.Beier J.P.Polykandriotis E.Bleiziffer O.Horch R.E.Kneser U. Dose-finding study of fibrin gel-immobilized vascular endothelial growth factor 165 and basic fibroblast growth factor in the arteriovenous loop rat modelTissue Eng Part A1525012009. 39. Arkudas, A., Pryymachuk, G., Hoereth, T., Beier, J.P., Polykandriotis, E., Bleiziffer, O., Horch, R.E., and Kneser, U. Dose-finding study of fibrin gel-immobilized vascular endothelial growth factor 165 and basic fibroblast growth factor in the arteriovenous loop rat model. Tissue Eng Part A 15, 2501, 2009.
40.
Freedman S.B. Clinical trials of gene therapy for atherosclerotic cardiovascular diseaseCurr Opin Lipidol136532002. 40. Freedman, S.B. Clinical trials of gene therapy for atherosclerotic cardiovascular disease. Curr Opin Lipidol 13, 653, 2002.
41.
Morishita R. Perspective in progress of cardiovascular gene therapyJ Pharmacol Sci9512004. 41. Morishita, R. Perspective in progress of cardiovascular gene therapy. J Pharmacol Sci 95, 1, 2004.
42.
Shah P.B.Losordo D.W. Non-viral vectors for gene therapy: clinical trials in cardiovascular diseaseAdv Genet543392005. 42. Shah, P.B., and Losordo, D.W. Non-viral vectors for gene therapy: clinical trials in cardiovascular disease. Adv Genet 54, 339, 2005.
43.
Ozawa C.R.Banfi A.Glazer N.L.Thurston G.Springer M.L.Kraft P.E. et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesisJ Clin Invest1135162004. 43. Ozawa, C.R., Banfi, A., Glazer, N.L., Thurston, G., Springer, M.L., Kraft, P.E., et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 113, 516, 2004.
44.
Bleiziffer O.Hammon M.Naschberger E.Lipnik K.Arkudas A.Rath S.Pryymachuk G.Beier J.P.Stürzl M.Horch R.E.Kneser U. Endothelial progenitor cells are integrated in newly formed capillaries and alter adjacent fibrovascular tissue after subcutaneous implantation in a fibrin matrixJ Cell Mol Med1524522011. 44. Bleiziffer, O., Hammon, M., Naschberger, E., Lipnik, K., Arkudas, A., Rath, S., Pryymachuk, G., Beier, J.P., Stürzl, M., Horch, R.E., and Kneser, U. Endothelial progenitor cells are integrated in newly formed capillaries and alter adjacent fibrovascular tissue after subcutaneous implantation in a fibrin matrix. J Cell Mol Med 15, 2452, 2011.
45.
Ley C.D.Olsen M.W.Lund E.L.Kristjansen P.E. Angiogenic synergy of bFGF and VEGF is antagonized by angiopoietin-2 in a modified in vivo Matrigel assayMicrovasc Res681612004. 45. Ley, C.D., Olsen, M.W., Lund, E.L., and Kristjansen, P.E. Angiogenic synergy of bFGF and VEGF is antagonized by angiopoietin-2 in a modified in vivo Matrigel assay. Microvasc Res 68, 161, 2004.
46.
Rophael J.A.Craft R.O.Palmer J.A.Hussey A.J.Thomas G.P.Morrison W.A. et al. Angiogenic growth factor synergism in a murine tissue engineering model of angiogenesis and adipogenesisAm J Pathol17120482007. 46. Rophael, J.A., Craft, R.O., Palmer, J.A., Hussey, A.J., Thomas, G.P., Morrison, W.A., et al. Angiogenic growth factor synergism in a murine tissue engineering model of angiogenesis and adipogenesis. Am J Pathol 171, 2048, 2007.
47.
Asahara T.Bauters C.Zheng L.P.Takeshita S.Bunting S.Ferrara N. et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivoCirculation92II3651995. 47. Asahara, T., Bauters, C., Zheng, L.P., Takeshita, S., Bunting, S., Ferrara, N., et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92, II365, 1995.
48.
Richardson T.P.Peters M.C.Ennett A.B.Mooney D.J. Polymeric system for dual growth factor deliveryNat Biotechnol1910292001. 48. Richardson, T.P., Peters, M.C., Ennett, A.B., and Mooney, D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 19, 1029, 2001.
49.
Cao R.Brakenhielm E.Pawliuk R.Wariaro D.Post M.J.Wahlberg E. et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2Nat Med96042003. 49. Cao, R., Brakenhielm, E., Pawliuk, R., Wariaro, D., Post, M.J., Wahlberg, E., et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9, 604, 2003.
50.
Moreno P.R.Purushothaman K.R.Sirol M.Levy A.P.Fuster V. Neovascularization in human atherosclerosisCirculation11322452006. 50. Moreno, P.R., Purushothaman, K.R., Sirol, M., Levy, A.P., and Fuster, V. Neovascularization in human atherosclerosis. Circulation 113, 2245, 2006.
51.
Khurana R.Simons M.Martin J.F.Zachary I.C. Role of angiogenesis in cardiovascular disease: a critical appraisalCirculation11218132005. 51. Khurana, R., Simons, M., Martin, J.F., and Zachary, I.C. Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 112, 1813, 2005.
52.
Horowitz J.R.Rivard A.van der Zee R.Hariawala M.Sheriff D.D.Esakof D.D. et al. Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endotheliumArterioscler Thromb Vasc Biol1727931997. 52. Horowitz, J.R., Rivard, A., van der Zee, R., Hariawala, M., Sheriff, D.D., Esakof, D.D., et al. Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium. Arterioscler Thromb Vasc Biol 17, 2793, 1997.
53.
Baumgartner I.Rauh G.Pieczek A.Wuensch D.Magner M.Kearney M. et al. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factorAnn Intern Med1328802000. 53. Baumgartner, I., Rauh, G., Pieczek, A., Wuensch, D., Magner, M., Kearney, M., et al. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann Intern Med 132, 880, 2000.
54.
Epstein S.E.Kornowski R.Fuchs S.Dvorak H.F. Angiogenesis therapy: amidst the hype, the neglected potential for serious side effectsCirculation1041152001. 54. Epstein, S.E., Kornowski, R., Fuchs, S., and Dvorak, H.F. Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects. Circulation 104, 115, 2001.
Information & Authors
Information
Published In
Tissue Engineering Part A
Volume 19 • Issue Number 11-12 • June 2013
Pages: 1327 - 1335
PubMed: 23394225
Copyright
Copyright 2013, Mary Ann Liebert, Inc.
History
Published in print: June 2013
Published ahead of print: 28 March 2013
Published online: 26 March 2013
Published ahead of production: 8 February 2013
Accepted: 3 January 2013
Received: 26 June 2012
Topics
- Adipose-derived stem cells
- Biomedical science, research and development
- Bone marrow mesenchymal stem cells
- Bone marrow stem cells
- Cell types
- Cellular phenomena
- DNA and cell biology
- Endothelial nitric oxide synthase
- Enzymes and coenzymes
- Genetic Engineering, Biotechnology, and Regenerative medicine
- Human adipose-derived stem cells
- Regenerative medicine
- Stem cell engineering
- Stem cells
- Tissue engineering
Authors
Disclosure Statement
Professor Morrison is an inventor on the Vascularized Tissue Graft patent and entitled to proceeds derived from commercialization of the patent, and is a board member and employee of the O'Brien Institute, which has an interest in the company charged with the commercialization of the Vascularized Tissue Graft patent. The remaining authors report no competing financial interests.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.